present in nine individuals (18%) each, whereas the mutation 6573 ϩ 1G→C was found in six individuals (12%). None of the patients was homozygous for the respective mutation; however, three patients were compound heterozygotes for two of these three recurrent mutations, respectively (see below). Examination of the current database consisting of 91 distinct COL7A1 mutations in 102 individuals with DEB failed to reveal the presence of these three mutations in non-Japanese patients (Uitto et al, 1999) .
Clinically, DEB manifests with a spectrum of phenotypic severity. The most severe, recessively inherited form, the Hallopeau-Siemens variant (HS-RDEB), manifests with extreme fragility of skin leading to extensive scarring and fusion of the digits (pseudosyndactyly), associated with extracutaneous manifestations such as esophageal strictures and corneal erosions. Later in life, development of aggressively metastasizing squamous cell carcinomas can lead to a premature demise of the individual affected by HS-RDEB. In the milder, so-called mitis forms, M-RDEB, protracted blistering leads to less pronounced scarring with little or no tendency for pseudosyndactyly; however, the clinical phenotype presents with a continuum of severity, and some patients are classified as HS/M-RDEB.
Three patients in which recurrent mutations in both alleles were delineated were examined in detail. Screening of Japanese DEB patients for recurrent mutations by restriction endonuclease digestions. Specifically, the 5818delC mutation destroys a restriction enzyme site for MspI (Christiano et al, 1995) , whereas the mutation 6573 ϩ 1G→C creates a new restriction enzyme site for MspI (Tamai et al, 1997) . The E2857X mutation destroys a restriction enzyme site for MaeI (Tamai et al, 1997) . The corresponding PCR products were digested with these restriction enzymes under conditions recommended by the manufacturer (Takara, Tokyo, Japan; Boehringer-Mannheim, Indianapolis, IN). The digestion products were examined on 3% agarose gels. Number of patients (n ϭ 50) 9 6 9 Per cent 18 12 18 Non-Japanese RDEB 0 0 0 patients (n ϭ 120) Patient 1 was a 39 y old Japanese man whose parents were unrelated and clinically unaffected. The clinical details of this patient consistent with the diagnosis of M-RDEB have been reported elsewhere (Fig 2A; Tamai et al , 1997) .
Patient 2 was a 40 y old Japanese male with generalized traumainduced blistering since birth. He had lost all fingernails and toenails, and developed severe syndactyly (Fig 2B) . The clinical presentation of this patient was clearly more severe than in Patient 1, but not as severe as in Patient 3. Clinically, this patient was classified as HS/M-RDEB.
Patient 3 was a 22 y old Japanese male with extensive and extremely severe blistering of the skin since birth. No other member of his family is affected, and his parents were not consanguineous. Marked scarring and ulcers were observed all over his body. Diffuse alopecia and almost complete syndactyly had developed (Fig 2C) . The clinical diagnosis was HS-RDEB.
Examination of the mutations in these three patients revealed that Patient 1 was a compound heterozygote for 6573 ϩ 1G→C/ E2857X, the two most 3Ј mutations of these three PTC mutations (Fig 2A) . In contrast, Patient 3 was compound heterozygote for 5818delC/6573 ϩ 1G→C, the two most 5Ј mutations (Fig 2C) . Patient 2 with intermediate severity was compound heterozygote for 5818delC/E2857X mutations (Fig 2B) . These results clearly indicate that mutation 6573 ϩ 1G→C, when compared with the more 5Ј mutation 5818delC, both superimposed on the common mutation E2857X in the other allele, results in a milder phenotype. On the other hand, mutation E2857X, by comparison with the mutation 6573 ϩ G→C, when both combined with the mutation 5818delC in the other allele, results in a milder phenotype (Fig 2) . These observations clearly suggest that the positions of the PTC mutations along the type VII collagen polypeptide can influence the clinical severity, and in general, the spectrum of genetic lesions in COL7A1 can underlie different clinical variants of DEB. The combinations and types of mutations as well as their positions along the type VII collagen molecules, superimposed on genetic background of the affected individual, collectively reflect the phenotypic variability observed in DEB.
Native Type I Collagen is Not a Substrate for MMP2 (Gelatinase A)
To the Editor:
A recent JID paper by Herouy et al. (1998) presented some interesting new data on lipodermatoschlerosis. Their interpretations of the data, however, are based upon a single paper in the MMP literature (Aimes and Quigley, 1995) , which claims that MMP2 (gelatinase A) is an interstitial collagenase, a claim that we have not been able to confirm. We were the first laboratory to purify, characterize, and clone human MMP2 (Seltzer et al, 1981; Collier et al, 1988) . We found that this proteinase had absolutely no activity against helical collagen. Native helical collagen is defined by its resistance to trypsin cleavage and characteristic viscosity in solution. Subsequent work from our laboratory has shown that MMP2 is an extremely opportunistic proteinase against any collagenous sequence in which the helicity is not perfect. For example, MMP2 cleaves helical type VII collagen within the helical portion of the molecule, but in an area that has relaxed helicity (Seltzer et al, 1989) . When the Aimes and Quigley paper was published we confirmed our original observations using pure TIMPfree MMP2 and helical collagen shown to be trypsin resistant. Interstitial type I collagen in which the helix was relaxed enough to render it susceptible to trypsin digestion was indeed susceptible to digestion by MMP2. Intact helical collagen was not. Ohuchi et al (1997) have recently reconfirmed our original findings.
Cleavage of interstitial collagen by MMP1 yields two characteristic fragments, which lose their helicity at 37°C and become soluble. Therefore, solubilization of type I collagen is not indicative of MMP2 activity, but is of MMP1 activity. Herouy et al clearly show active MMP1 in their western immunoblots, indicating that cleavage of labeled type I collagen by their extracts can definitely occur.
It is important to point out that TIMP-MMP complexes have been previously described, but are separated when subjected to SDS-PAGE electrophoresis Wilhelm et al, 1989) . The high molecular weight band shown in the immunoblots (Fig 2) by Herouy et al (1998) Reply Lipodermatosclerosis is characterized by distinct morphologic features. Prominent perivascular fibrin cuffs and deposition of hemosiderin pigments due to red blood cell extravasation are major tissue changes occurring in patients with severe chronic venous insufficiency. Perivascular cuffs are highly organized structures primarily composed of fibrin, laminin, fibronectin, tenascin and type I and III collagens (Herrick et al, 1992) . Fibrous scar tissue associated with fragmentation of elastic fibers and loss of papillary structures at the dermal-epidermal junction are further histologic findings. The dermal-epidermal junction is built up by an extraordinarily complex network of interconnecting proteins such as different collagen subtypes and laminin (Burgeson and Christiano, 1997).
To understand the molecular basis of these morphologic alterations
